Digital CRO Clinipace grabs $15M round

Clinipace Worldwide, a growing CRO with proprietary clinical trials software, has fueled the expansion of its business with a fresh $15 million Series C round. Morgan Stanley Expansion Capital led the round, which included investments from Hatteras Venture Partners and Brook Private Equity Advisors. With its restocked coffers, the Morrisville, NC-based contract research group will continue its growth with a focus on serving emerging and mid-sized biotechs along with medical device outfits. In recent years, the company has grown through multiple acquisitions. Article